Unknown

Dataset Information

0

Investigating the prevalence, predictors, and prognosis of suboptimal statin use early after a non-ST elevation acute coronary syndrome.


ABSTRACT: BACKGROUND:High-potency statin therapy is recommended in the secondary prevention of cardiovascular disease but discontinuation, dose reduction, statin switching, and/or nonadherence occur in practice. OBJECTIVES:To determine the prevalence and predictors of deviation from high-potency statin use early after a non-ST elevation acute coronary syndrome (NSTE-ACS) and its association with subsequent major adverse cardiovascular events (MACE) and all-cause mortality (ACM). METHODS:A total of 1005 patients from a UK-based prospective NSTE-ACS cohort study discharged on high-potency statin therapy (atorvastatin 80 mg, rosuvastatin 20 mg, or 40 mg daily) were included. At 1 month, patients were divided into constant high-potency statin users, and suboptimal users incorporating statin discontinuation, dose reduction, switching statin to a lower equivalent potency, and/or statin nonadherence. Follow-up was a median of 16 months. RESULTS:There were 156 suboptimal (?15.5%) and 849 constant statin users. Factors associated in multivariable analysis with suboptimal statin occurrence included female sex (odds ratio 1.75, 95% confidence interval [CI] 1.14-2.68) and muscular symptoms (odds ratio 4.28, 95% CI 1.30-14.08). Suboptimal statin use was associated with increased adjusted risks of time to MACE (hazard ratio 2.10, 95% CI 1.25-3.53, P = .005) and ACM (hazard ratio 2.46, 95% CI 1.38-4.39, P = .003). Subgroup analysis confirmed that the increased MACE/ACM risks were principally attributable to statin discontinuation or nonadherence. CONCLUSIONS:Conversion to suboptimal statin use is common early after NSTE-ACS and is partly related to muscular symptoms. Statin discontinuation or non-adherence carries an adverse prognosis. Interventions that preserve and enhance statin utilization could improve post NSTE-ACS outcomes.

SUBMITTER: Turner RM 

PROVIDER: S-EPMC5399750 | biostudies-literature | 2017 Jan - Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Investigating the prevalence, predictors, and prognosis of suboptimal statin use early after a non-ST elevation acute coronary syndrome.

Turner Richard M RM   Yin Peng P   Hanson Anita A   FitzGerald Richard R   Morris Andrew P AP   Stables Rod H RH   Jorgensen Andrea L AL   Pirmohamed Munir M  

Journal of clinical lipidology 20161228 1


<h4>Background</h4>High-potency statin therapy is recommended in the secondary prevention of cardiovascular disease but discontinuation, dose reduction, statin switching, and/or nonadherence occur in practice.<h4>Objectives</h4>To determine the prevalence and predictors of deviation from high-potency statin use early after a non-ST elevation acute coronary syndrome (NSTE-ACS) and its association with subsequent major adverse cardiovascular events (MACE) and all-cause mortality (ACM).<h4>Methods<  ...[more]

Similar Datasets

| S-EPMC9851415 | biostudies-literature
| S-EPMC8509190 | biostudies-literature
| S-EPMC9918164 | biostudies-literature
| S-EPMC6405683 | biostudies-literature
| S-EPMC8761910 | biostudies-literature
| S-EPMC9605400 | biostudies-literature
| S-EPMC7214884 | biostudies-literature
| S-EPMC7419413 | biostudies-literature
| S-EPMC9489762 | biostudies-literature
| S-EPMC9443038 | biostudies-literature